A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia

被引：0

作者：

Cheng, Shengqin ^{[1
]}

Gao, Li ^{[1
]}

Wang, Yi ^{[1
]}

Xiao, Peifang ^{[1
]}

He, Hailong ^{[1
]}

Lu, Jun ^{[1
]}

Li, Jie ^{[1
]}

Hu, Yixin ^{[1
]}

Fan, Liyan ^{[1
]}

Ribeiro, Raul C. ^{[2
]}

Cheng, Cheng ^{[3
]}

Hu, Shaoyan ^{[1
]}

机构：

[1] Soochow Univ, Dept Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China

[2] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA

[3] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-188040

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Fludarabine, Cytarabine and G-CSF (FLAG) as treatment of de novo acute myeloid leukemia with multilineage dysplasia.
Ferrara, F
Palmieri, S
Schiavone, EM
Annunziata, M
Copia, C
Annunziata, S
Gianfaldoni, G
Leoni, F
BLOOD, 2001, 98 (11) : 212B - 212B
[2] A phase Ⅳ study of homoharringtonine, cytarabine, aclacinomycin and G-CSF(HCAG) regimen compared with traditional IA regimen in the treatment of newly diagnosed elderly acute myeloid leukemia patients
刘钊
张赟翔
王丽宁
XIA Zheng
MAO Yuan-fei
ZHAO Hui-jin
YOU Jian-hua
YU Yang
ZHAO Yu-bing
REN Yu-hong
LI Ya
WANG Yan
CHEN Qiu-sheng
李军民
陈瑜
上海交通大学学报(医学版), 2017, 37 (08) : 1100 - 1105
[3] Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
Montillo, M
Mirto, S
Petti, MC
Latagliata, R
Magrin, S
Pinto, A
Zagonel, V
Mele, G
Tedeschi, A
Ferrara, F
AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (02) : 105 - 109
[4] Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
Zhu, Jun-Feng
Dai, Hai-Ping
Zhang, Qian-Qian
Yin, Jia
Li, Zheng
Cui, Qin-Ya
Tian, Xiao-Peng
Liu, Si-Ning
Jin, Zheng-Ming
Zhu, Xia-Ming
Wu, De-Pei
Tang, Xiao-Wen
FRONTIERS IN ONCOLOGY, 2022, 12
[5] Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia
Wang, Huafeng
Mao, Liping
Xie, Wanzhuo
Tong, Hongyan
Yang, Min
Xu, Gaixiang
Ye, Xiujin
Lu, Ying
Wei, Juying
Mai, Wenyuan
Zhou, De
Jin, Jie
Zhu, Hong-Hu
BLOOD, 2021, 138
[6] The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia
Hubeek, I
Litvinova, E
Peters, GJ
Broekhuizen, R
Haarman, EG
Huismans, DR
Cloos, J
Zwaan, CM
Fleischhack, G
Creutzig, U
Kaspers, GJL
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (06) : 1823 - 1829
[7] Phase I Trial Combining Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) for Patients with Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms
Raychaudhuri, Suravi
Gooley, Ted
Rasmussen, Allegra
Quach, Kim
Gill, Zach
Halpern, Anna B.
Appelbaum, Jacob S.
Ghiuzeli, Cristina Maria
Hendrie, Paul C.
Cassaday, Ryan D.
Walter, Roland B.
Estey, Elihu
Percival, Mary-Elizabeth M.
BLOOD, 2024, 144 : 4288 - 4289
[8] HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants
Xie, Mixue
Jiang, Qi
Li, Li
Zhu, Jingjing
Zhu, Lixia
Zhou, De
Zheng, Yanlong
Yang, Xiudi
Zhu, Mingyu
Sun, Jianai
Xie, Wanzhuo
Ye, Xiujin
PLOS ONE, 2016, 11 (10):
[9] Venetoclax Combined with Azacitidine and Homoharringtonine in Adults with Secondary Acute Myeloid Leukemia
Huang, Fei
Chen, Yu
Shi, Zhongxun
Huang, Huijun
Li, Jianyong
Shen, Wenyi
BLOOD, 2023, 142
[10] Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study
Carella, AM
Cascavilla, N
Greco, MM
Melillo, L
Sajeva, MR
Ladogana, S
D'Arena, G
Perla, G
Carotenuto, M
LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 295 - 303

← 1 2 3 4 5 →